Exact Mass: 442.3307592
Exact Mass Matches: 442.3307592
Found 355 metabolites which its exact mass value is equals to given mass value 442.3307592,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Testosterone Decanoate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Ascorbyl stearate
Ascorbyl stearate is a preservative for margarine Ascorbyl stearate (C24H42O7) is an ester formed from ascorbic acid and stearic acid. In addition to its use as a source of vitamin C, it is used as an antioxidant food additive in margarine (E number E305). The USDA limits its use to 0.02\\% individually or in conjunction with other antioxidants Preservative for margarine
4a-Carboxy-4b-methyl-5a-cholesta-8,24-dien-3b-ol
Intermediate in Cholesterol biosynthesis [HMDB] Intermediate in Cholesterol biosynthesis.
(3beta,22E,24R)-5,8-Epidioxy-23-methylergosta-6,22-dien-3-ol
(3beta,22E,24R)-5,8-Epidioxy-23-methylergosta-6,22-dien-3-ol is found in mushrooms. (3beta,22E,24R)-5,8-Epidioxy-23-methylergosta-6,22-dien-3-ol is a constituent of Lentinus edodes (shiitake) Constituent of Lentinus edodes (shiitake). (3beta,22E,24R)-5,8-Epidioxy-23-methylergosta-6,22-dien-3-ol is found in mushrooms.
(3beta,5alpha,9alpha,22E,24R)-5,9-Epidioxy-3-hydroxyergosta-7,22-dien-6-one
(3beta,5alpha,9alpha,22E,24R)-5,9-Epidioxy-3-hydroxyergosta-7,22-dien-6-one is found in mushrooms. (3beta,5alpha,9alpha,22E,24R)-5,9-Epidioxy-3-hydroxyergosta-7,22-dien-6-one is a constituent of Hypsizygus marmoreus (bunashimeji) and Pleurotus ostreatus (oyster mushroom)
(all-E)-6'-Apo-y-caroten-6'-al
(all-E)-6-Apo-y-caroten-6-al is found in garden tomato. (all-E)-6-Apo-y-caroten-6-al is isolated from Lycopersicon esculentum (tomato). Isolated from Lycopersicon esculentum (tomato). (all-E)-6-Apo-y-caroten-6-al is found in garden tomato and garden tomato (variety).
Camellenodiol
Camellenodiol is found in fats and oils. Camellenodiol is a constituent of Camellia japonica Constituent of Camellia japonica. Camellenodiol is found in tea and fats and oils.
4a-Methylzymosterol-4-carboxylic acid
4alpha-Methylzymosterol-4-carboxylic acid is a steroid derivative involved in steroid biosynthesis. It is generated from 14-demethyl-lanosterol via the enzyme methylsterol monooxygenase (EC 1.14.13.72).
2,3-Diacetoxypropyl stearate
2,3-Diacetoxypropyl stearate belongs to the family of Fatty Acid Esters. These are carboxylic ester derivatives of a fatty acid.
4-Methylzymosterol intermediate 1
This compound belongs to the family of Triterpenes. These are terpene molecules containing 8 isoprene units. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
4α-carboxy-4β-methyl-5α-cholesta-8,24-dien-3β-ol
4α-carboxy-4β-methyl-5α-cholesta-8,24-dien-3β-ol is also known as 4alpha-Carboxy-4beta-methyl-zymosterol. 4α-carboxy-4β-methyl-5α-cholesta-8,24-dien-3β-ol is considered to be practically insoluble (in water) and acidic. 4α-carboxy-4β-methyl-5α-cholesta-8,24-dien-3β-ol is a sterol lipid molecule
DG(8:0/15:0/0:0)
DG(8:0/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/15:0)
DG(8:0/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/i-15:0/0:0)
DG(8:0/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/i-15:0)
DG(8:0/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/a-15:0/0:0)
DG(8:0/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/a-15:0)
DG(8:0/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(10:0/13:0/0:0)
DG(10:0/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/13:0)
DG(10:0/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(10:0/i-13:0/0:0)
DG(10:0/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/i-13:0)
DG(10:0/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(10:0/a-13:0/0:0)
DG(10:0/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/a-13:0)
DG(10:0/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(13:0/10:0/0:0)
DG(13:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(13:0/0:0/10:0)
DG(13:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/10:0/0:0)
DG(i-13:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/0:0/10:0)
DG(i-13:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/10:0/0:0)
DG(a-13:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/0:0/10:0)
DG(a-13:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(15:0/8:0/0:0)
DG(15:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(15:0/0:0/8:0)
DG(15:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-15:0/8:0/0:0)
DG(i-15:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-15:0/0:0/8:0)
DG(i-15:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-15:0/8:0/0:0)
DG(a-15:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-15:0/0:0/8:0)
DG(a-15:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
N-Palmitoyl Tryptophan
C27H42N2O3 (442.31952620000004)
N-palmitoyl tryptophan belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Palmitic acid amide of Tryptophan. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Palmitoyl Tryptophan is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Palmitoyl Tryptophan is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
N-Docosahexaenoyl Asparagine
N-docosahexaenoyl asparagine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Asparagine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl Asparagine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl Asparagine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Alnespirone
Elocalcitol
Testosterone decanoate
24-Oxo-5alpha-cholesta-7-en-3beta-ylacetat|24-oxolathosteryl acetate
(20S)-20-(N,N-dimethylamino)-3beta-(N-senecoylamino)-5alpha-pregn-16-en-4beta-ol|hookerianamide J
C28H46N2O2 (442.35590959999996)
3beta,18beta-dihydroxy-28-norolean-12-en-16-one|camellenodiol
3alpha-(5-methyldodeca-2E,4E,6E-trienoyloxy)-9alpha-hydroxy-10alphaH-eremophil-7(11)-ene-8-one|3alpha-<5-methyldodeca-2E,4E,6E-trienoyloxy>-9alpha-hydroxy-10alphaH-eremophil-7(11)-ene-8-one
5alpha,8alpha-epidioxy-24(S/R)-ethylcholesta-6,22-dien-3beta-ol
28-hydroxy-3,20-dioxo-29-norlupane|3,20-dioxo-29-nor-lup-28-ol
(2E,6E,10E)-1-(2-hydroxy-5-methoxy-3-methylphenyl)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-5,12-diol|(2E,6E,10E,14E)-1-(1-hydroxy-4-methoxy-6-methyl phenyl)-5,12-dihydroxy-3,7,11,15-tetramethyl hexadeca-2,6,10,14-tetraene
(3beta)-3,13-dihydroxy-27-norolean-28-oic acid gamma-lactone|(3beta)-3-hydroxy-27-noroleano-13(28)-lactone
22E-7alpha-methoxy-5alpha,6alpha-epoxyergosta-8(14),22-dien-3beta-ol
(22R,23R,24R)-5alpha,8alpha-epidioxy-22,23-methylene-24-methylcholest-6-en-3beta-ol
(3beta,5alpha,8alpha)-5,8-Epidioxy-24-ethylcholesta-6,24(28)-dien-3-ol
(24R,25R,27R)-5alpha,6alpha-epoxy-26,27-cyclo-24,27-dimethylcholest-8(14)-ene-3beta,7alpha-diol|topsentisterol B3
N-methylfluvirucin A1
A lactam that is 4-hydroxyazacyclotetradecan-2-one substituted by an ethyl group at position 11, methyl group at positions 3 and 7 and a 3,6-dideoxy-3-(methylamino)-alpha-L-talopyranosyl moiety at position 4 via a glycosyl linkage (the 3R,4S,7R,11S stereoisomer). It is isolated from the fermentation broth of Nonomuraea turkmeniaca MA7364 and exhibits anthelminthic activity. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
Ac-12alpha-Hydroxy-24-methyl-24-oxo-16-scalaren-25-al-
(22R,24R)-22,24-epoxy-7,25-dihydroxyergosta-1,4-dien-3-one
(20S,22R)-1alpha,3beta-dihydroxy-witha-5,24-dienolide
24xi-hydroperoxy-24-ethylcholesta-4,28(29)-dien-3-one
3beta,25,29-trihydroxy-5alpha-stigmasta-8(9),14(15),24Z(28)-triene
(22E,24R)-3beta,5alpha-dihydroxy-23-methylergosta-7,22-dien-6-one
22E-3beta-hydroxy-5alpha,6alpha,8alpha,14alpha-diepoxyergost-22-en-7-one
(16beta,22E)-16,18,20-Trihydroxy-24-methylcholesta-1,4,22-trien-3-one
petuniasterone C|petuniasterone C ( (22R,24S)-24,25-epoxy-7alpha,22-dihydroxyergosta-1,4-dien-3-one )
3-oxo-21alpha-ethoxy-24,25,26,27-tetranortirucall-7-ene-23(21)-lactone
9,19-Cyclocholan-24-al, 3-(acetyloxy)-4,4,14-trimethyl-, (3.beta.,5.alpha.)-
(2R)-2,7,8-trimethyl-2-[(3E,7E)-4,8-dimethyl-13-hydroxy-12-hydroxymethyldeca-3,7,11-trienyl]chroman-6-ol|gamma-amplexichromanol
5alpha-stigmasta-7,9(11),24(28)Z-triene-3beta,26,29-triol
3-oxo-20-hydroxy-30beta-methyl,17(29)alpha-epoxy-28-norlupane
(2E,20S)-20-(dimethylamino)-2beta-hydroxy-3beta-(tigloylamino)pregn-14-ene|2-hydroxysalignamine-E|2-hydroxysalignarine-E
C28H46N2O2 (442.35590959999996)
22alpha-hydroxy-(24R)-ethylcholesta-4,9(11)dien-3-one|haloxysterol C
(5alpha,11alpha,22E,24S)-11-Hydrocystigmast-22-ene-3,6-dione
5alpha,9alpha-epidioxy-8alpha,14alpha-epoxy-(22E)-ergosta-6,22-dien-3beta-ol|5??,9??-Epidioxy-8??,14??-epoxy-(22E)-ergosta-6,22-dien-3??-ol
(6S)-hydroxy-29-nor-3,4-seco-cycloart-4(30),24-dien-3-oic acid
(3beta,4beta)-3,4-dihydroxy-24,30-dinoroleana-12,20(29)-dien-28-oic acid|paeonenoide C
(3beta,24R)-3,9-dihydroxy-4-methylideneergost-8(14)-en-15-one|9alpha-hydroxy-15-oxoconicasterol
(2E,6E)-5-hydroxy-1-(2-hydroxy-5-methoxy-3-methylphenyl)-3,7,11,15-tetramethylhexadeca-2,6,14-trien-12-one|(2E,6E,14E)-1-(1-hydroxy-4-methoxy-6-methylphenyl)-5-hydroxy-12-one-3,7,11,15-tetramethyl hexadeca-2,6,14-triene|5-hydroxy-12-oxohalidrol
Stearoyl Serotonin
C28H46N2O2 (442.35590959999996)
4-[3-methyl-5-(5,6,7-trihydroxy-1,2,4a,5-tetramethyl-3,4,6,7,8,8a-hexahydro-2H-naphthalen-1-yl)pentoxy]-4-oxobutanoic acid
4-[3-methyl-5-(5,6,7-trihydroxy-1,2,4a,5-tetramethyl-3,4,6,7,8,8a-hexahydro-2H-naphthalen-1-yl)pentoxy]-4-oxobutanoic acid [IIN-based on: CCMSLIB00000848208]
4-[3-methyl-5-(5,6,7-trihydroxy-1,2,4a,5-tetramethyl-3,4,6,7,8,8a-hexahydro-2H-naphthalen-1-yl)pentoxy]-4-oxobutanoic acid [IIN-based: Match]
Ala Lys Lys Pro
Ala Lys Pro Lys
Ala Pro Lys Lys
Ile Ile Val Val
Ile Leu Val Val
Ile Val Ile Val
Ile Val Leu Val
Ile Val Val Ile
Ile Val Val Leu
Lys Ala Lys Pro
Lys Ala Pro Lys
Lys Lys Ala Pro
Lys Lys Pro Ala
Lys Pro Ala Lys
Lys Pro Lys Ala
Leu Ile Val Val
Leu Leu Val Val
Leu Val Ile Val
Leu Val Leu Val
Leu Val Val Ile
Leu Val Val Leu
Pro Ala Lys Lys
Pro Lys Ala Lys
Pro Lys Lys Ala
Val Ile Ile Val
Val Ile Leu Val
Val Ile Val Ile
Val Ile Val Leu
Val Leu Ile Val
Val Leu Leu Val
Val Leu Val Ile
Val Leu Val Leu
Val Val Ile Ile
Val Val Ile Leu
Val Val Leu Ile
Val Val Leu Leu
1α,25-dihydroxy-24-methylvitamin D2 / 1α,25-dihydroxy-24-methylergocalciferol
(5Z,7E)-(1S,3R,20R,22S)-24a-homo-9,10-seco-5,7,10(19)-cholestatrien-23-yne-1,3,22,25-tetrol
18-acetoxy-vitamin D3 / 18-acetoxy-cholecalciferol
1α,25-dihydroxy-11α-vinylvitamin D3 / 1α,25-dihydroxy-11α-vinylcholecalciferol
(5Z,7E,22E)-(1S,3R)-26,27-dimethyl-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,25-triol
(5Z,7E,22E)-(1S,3R)-24a,24b-dihomo-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,25-triol
1α,25-dihydroxy-26,27-ethanovitamin D3 / 1α,25-dihydroxy-26,27-ethanocholecalciferol
(5Z,7E)-(1S,3R)-18-(4-hydroxy-4-methyl-2-pentynyloxy)-23,24-dinor-9,10-seco-5,7,10(19)-cholatriene-1,3-diol
(5Z,7E,24E)-(1S,3R)-24a,24b-dihomo-9,10-seco-5,7,10(19),24-cholestatetraene-1,3,25-triol
(5Z,7E,24aE)-(1S,3R)-24a,24b-dihomo-9,10-seco-5,7,10(19),24a-cholestatetraene-1,3,25-triol
25-Hydroxy[26,27-methyl]vitamin D3 3β-(1,2-epoxypropyl)ether
4-[(2,5-dioxo-4-Imidazolidinylidene)methyl)-benzaldehyde
(3beta,22E,24R)-5,8-Epidioxy-23-methylergosta-6,22-dien-3-ol
Camellenodiol
6'-Apo-psi,psi-carotenal
ascr#33
An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E,18R)-18-hydroxynonadec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
oscr#33
An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E)-19-hydroxynonadec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
1alpha,25-dihydroxy-24-methylvitamin D2
(22S)-1alpha,22,25-trihydroxy-23,24-tetradehydro-24a-homo-20-epivitamin D3
1alpha,25-dihydroxy-11alpha-vinylvitamin D3
1alpha,25-dihydroxy-26,27-ethanovitamin D3
25-Hydroxy[26,27-methyl]vitamin D3 3beta-(1,2-epoxypropyl)ether
Mazipredone
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
N,N-Dibenzyl-1,4,10,13-tetraoxa-7,16-diazacyclooctadecane
1-N,3-N-bis(2,2,6,6-tetramethylpiperidin-4-yl)benzene-1,3-dicarboxamide
Elocalcitol
D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols
trans,trans-4-(4-Pentyl-bicyclohexyl-4-yl)-3,4,5-trifluorobiphenyl
(S)-1-((S)-3,3-Dimethyl-2-((S)-2-(methylamino)propanamido)butanoyl)-N-((R)-1,2,3,4-tetrahydronaphthalen-1-yl)pyrrolidine-2-carboxamide
8-[4-[Propyl(5-methoxychroman-3-yl)amino]butyl]-8-azaspiro[4.5]decane-7,9-dione
Hookerianamide J
C28H46N2O2 (442.35590959999996)
A steroid alkaloid that is 5alpha-preg-16-ene substituted by a hydroxy group at position 4, a N,N-dimethylamino group at position 20 and a N-senecoylamino group at position 3 (the 3beta,4beta,20S stereoisomer). Isolated from Sarcococca hookeriana, it exhibits antileishmanial and antibacterial activities.
(2E)-19-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]nonadec-2-enoic acid
(2E,18R)-18-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]nonadec-2-enoic acid
3-Hydroxy-4,10,13-trimethyl-17-(6-methylhept-5-en-2-yl)-1,2,3,5,6,7,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-4-carboxylic acid
N-[2-(5-Hydroxy-1H-indol-3-yl)ethyl]octadecanamide
C28H46N2O2 (442.35590959999996)
3-hydroxy-10,13-dimethyl-17-(6-methyl-5-methylideneheptan-2-yl)-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-4-carboxylic acid
3beta-Hydroxy-4alpha-methyl-5alpha-cholesta-8,24-diene-4beta-carboxylic acid
(3S,4S,5S,10S,13R,14R,17R)-17-[(2R,5S)-5,6-dimethylhept-6-en-2-yl]-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-4-carboxylic acid
(3beta,5alpha,9alpha,22E,24R)-5,9-Epidioxy-3-hydroxyergosta-7,22-dien-6-one
(3Z)-3-[(2E)-2-[1-[(E)-6-ethyl-6-hydroxyoct-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-5-fluoro-4-methylidenecyclohexan-1-ol
[3-Carboxy-2-(3-oxooctadecanoyloxy)propyl]-trimethylazanium
[3-carboxy-2-[(Z)-3-hydroxyoctadec-9-enoyl]oxypropyl]-trimethylazanium
[(2R)-3-carboxy-2-[(Z,3R)-3-hydroxyoctadec-11-enoyl]oxypropyl]-trimethylazanium
[(2R)-3-carboxy-2-[(Z,3R)-3-hydroxyoctadec-9-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-9-hydroxyoctadec-12-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-10-hydroxyoctadec-12-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-12-hydroxyoctadec-9-enoyl]oxypropyl]-trimethylazanium
[(E)-2-(carboxymethyl)-2,20-dihydroxy-3-oxoicos-4-enyl]-trimethylazanium
5alpha,8alpha-Epidioxysterol
A 3beta-sterol that consists of 24-methylcholest-6-en-3beta-ol with a peroxy group between positions 5 and 8 and a methylene group between positions 22 and 23. An antineoplastic agent isolated from Sinularia sp.
Rel-2alpha,3beta,23-trihydroxy-12,17-dien-28-norursane
A pentacyclic triterpenoid based on a ursane-type nortriterpene skeleton isolated from the leaves of found in Rosa laevigata.
2-(1-adamantyl)-N-[2,5-diethoxy-4-(4-morpholinyl)phenyl]acetamide
4-[3-methyl-5-(5,6,7-trihydroxy-1,2,4a,5-tetramethyl-3,4,6,7,8,8a-hexahydro-2H-naphthalen-1-yl)pentoxy]-4-oxobutanoic acid
1-[3-methyl-2-[2-(methylamino)propanoylamino]pentanoyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)pyrrolidine-2-carboxamide
[(1S)-3-carboxy-1-[(Z)-3-hydroxyoctadec-11-enoyl]oxypropyl]-trimethylazanium
[(1S)-3-carboxy-1-[(Z)-3-hydroxyoctadec-9-enoyl]oxypropyl]-trimethylazanium
12-Trimethylsilyloxy-9-octadecenoic acid, trimethylsilyl ester
(1-Heptanoyloxy-3-hydroxypropan-2-yl) hexadecanoate
(1-Hydroxy-3-nonanoyloxypropan-2-yl) tetradecanoate
(1-Hydroxy-3-undecanoyloxypropan-2-yl) dodecanoate
(1-Butanoyloxy-3-hydroxypropan-2-yl) nonadecanoate
(1-Hydroxy-3-octanoyloxypropan-2-yl) pentadecanoate
(1-Hydroxy-3-pentanoyloxypropan-2-yl) octadecanoate
(1-Hexanoyloxy-3-hydroxypropan-2-yl) heptadecanoate
(5R,6S,9S,11R,13S,15S,16S,17R,19S,21S)-6,21-dimethyl-21-(4-methyl-3-methylidenepentyl)-14,18,20-trioxaheptacyclo[15.4.1.02,16.02,19.05,15.06,11.013,15]docosan-9-ol
[(2S)-3-hydroxy-2-undecanoyloxypropyl] dodecanoate
[(2S)-1-hydroxy-3-undecanoyloxypropan-2-yl] dodecanoate
[1-carboxy-3-[2-hydroxy-3-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]propyl]-trimethylazanium
C24H44NO6+ (442.31684640000003)
4alpha-Methylzymosterol-4-carboxylate
(5Z,7E)-(1S,3R)-26,27-ethano-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
4beta-methylzymosterol-4alpha-carboxylic acid
A 3beta-sterol that consists of 4beta-methylzymosterol in which the 4alpha-hydrogen is replaced by a carboxy group.
TG(22:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
NA-Orn 22:6(4Z,7Z,10Z,13Z,16Z,19Z)
C27H42N2O3 (442.31952620000004)